Iloprost Therapy in Patients With Critical Limb Ischemia: Evaluation of Efficacy and Safety

Trial Profile

Iloprost Therapy in Patients With Critical Limb Ischemia: Evaluation of Efficacy and Safety

Completed
Phase of Trial: Phase IV

Latest Information Update: 05 Mar 2015

At a glance

  • Drugs Iloprost (Primary)
  • Indications Embolism and thrombosis; Peripheral arterial disorders; Peripheral ischaemia
  • Focus Therapeutic Use
  • Sponsors Bayer
  • Most Recent Events

    • 01 Mar 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 07 Dec 2014 Planned End Date changed from 1 Sep 2014 to 1 Dec 2014 as reported by ClinicalTrials.gov record.
    • 05 Sep 2014 Planned End Date changed from 1 Jul 2014 to 1 Sep 2014, as reported by the ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top